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Phaleria macrocarpa (Scheff.) Boerl. has been widely used in the treatment of diabetes 
mellitus but its effectiveness is still inconclusive so it needs to be compared with 
standard drugs such as metformin. This study aims to analyze the effects of P. 
macrocarpa fruit extracts on blood sugar levels and the repairing of the pancreatic 
Langerhans islets of diabetic rat models. The study was conducted experimentally by 
pre and post-test design with a control group. Thirty white rats were divided into 6 
groups. All rats were treated with 40 mg/200 g BW of streptozotocin (STZ) to induce 
hyperglycemia, except group I. Group II as a negative control was given with aquadest. 
Group III, IV, and V were given with ethanol extract of P. macrocarpa pericarps at doses 
of 200, 250, and 300 mg/200 g BW/day, respectively. Group VI was given with 
metformin at a dose of 150 mg/200 g BW/day. On the 22nd day of treatment, blood 
specimens were taken for examination of fasting blood sugar levels and pancreatic 
organs were analyzed for histopathological examination of the islets of pancreatic 
Langerhans. The data were statistically analyzed with α<0.05; CI95%. Paired sample t-
test results showed a significant decrease in blood sugar levels before and after 
treatment in group V (p-value=0.048). One way anova and post hoc Least Significant 
Difference (LSD) test results showed a significant difference in mean blood sugar levels 
after the final treatment between groups I and II (p-value=0.013), I and III (p-
value=0.004), I and IV (p-value=0.002), I and VI (p-value=0.000), II and VI (p-
value=0.031), and V with VI (p-value=0.005); one way anova and post hoc LSD test 
results showed a significant difference in the mean area of islets of pancreatic 
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Langerhans between group I and all treatment groups (p-value=0.000), II with V and VI 
(p-value=0.000 and 0.009), III with V and VI (p-value=0.000 and 0.001), and IV with V (p-
value=0.003). It can be concluded that the extract of P. macrocarpa pericarps showed a 
hypoglycemic effect and repaired the damage in Langerhans islets of STZ-induced rat in 
a dose-dependent manner.  
 





Diabetes mellitus (DM) is still a 
health problem in the world and is one 
of the five main causes of death 
(Erejuwa et al., 2011; WHO, 2016). In 
2012, diabetes caused 1.5 million death 
in the world (WHO, 2016). The number 
of DM patients in the world is estimated 
to continue to increase to 592 million by 
2035. Indonesia is ranked seventh with 
the highest prevalence of DM in the 
world with the number of people who 
live in diabetes expected to reach more 
than 14.1 million in 2035 (International 
Diabetes Federation, 2013). 
DM is a serious chronic 
metabolic disease due to damage to the 
pancreas so that it cannot produce 
enough insulin and also due to the 
body's inability to use insulin (insulin 
resistance). This condition will cause an 
increase in blood sugar levels, which is 
called hyperglycemia. Persistent 
hyperglycemia triggers an increase in 
Reactive Oxygen Species (ROS) which 
induces excessively increase in free 
radicals. Excessive free radicals cause 
oxidative stress and cause damage to β 
cells in the islets of Langerhans (Novelli 
et al., 2014). Damage of betha-cells 
results in reduced clusters of β cells that 
cause atrophy at the size of the islets of 
Langerhans. The decrease in size 
(atrophy) of the islets of Langerhans 
reaching 60% of volume which can also 
stimulated by the insulin hypersecretion 
due to insulin resistance which cause 
increasing of insulin need. 
Hypersecretion of insulin increases 
endoplasmic and mitochondrial 
reticulum activity which ultimately 
increases free radical accumulation. 
(Judiono et al., 2009; Jones et al., 2010). 
Significant changes in the 
histological structure of the islets of 
Langerhans are one of the typical 
pathological features and are often 
found in patients and animal models of 
diabetes. These changes occur due to 
glucotoxicity due to chronic 
hyperglycemia in the β cells of the islets 
of Langerhans, which occur both 
quantitatively (atrophy of the islets of 
Langerhans), and qualitatively (necrosis, 
degeneration, and amyloidosis) 
(Suarsana et al., 2010). On pancreatic 
histological examination, the size of the 
Langerhans islests can be expressed in 
terms of diameter, area, and volume.  
Until now, metformin is still a 
mainstay drug in the treatment of 
diabetes, especially type-2 DM. 
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Metformin is a class of biguanide drugs 
that are believed to improve insulin 
sensitivity, increase peripheral glucose 
use, and reduce glucose release from 
the liver (Bjornstad et al., 2018; Cree-
Green et al., 2019). Metformin can 
prevent glucotoxicity and reduce 
oxidative stress due to free radical 
formation (Zhou et al., 2018). The 
combination of metformin and L-
cysteine have been shown to suppress 
insulin resistance in streptozotocin-
induced type 2 diabetic rats, while in 
monotherapy, metformin shown ability 
to significantly reduce oxidative stress, 
serum free fatty acids (FFAs) levels, and 
inflammatory markers, caspase-3, and 
cytochrome c levels which can inhibit 
cells apoptosis (Salman et al., 2013). 
Murad et al. (2015) showed that 
metformin could increase regeneration 
of Langerhans islets and reduce 
oxidative stress in Sprague Dawley rats 
with diabetes models.  
Phaleria macrocarpa (Scheff.) 
Boerl. is an herbal medicine that has 
been widely used by the people of 
Indonesia as an anti-diabetes drug. The 
compounds contained in P. macrocarpa 
fruit include tannin, terpenoids, hydroxy 
benzophenone glucoside, alkaloids, 
flavonoids, saponins, and polyphenols 
(Hendra et al., 2011). Alkaloids, 
saponins, and flavonoids are 
compounds that have antioxidant 
effects. Arjadi and Priyo's research 
(2010) shows that the giving of diced 
flesh of P. macrocarpa can regenerate 
Langerhans island β cells which is 
marked by an increase in the average 
number of Langerhans island β cells and 
an increase in Langerhans island 
diameter.  Antioxidants effect of 
flavonoids can protect the islets of 
Langerhans from free radicals while the 
alkaloids have the ability to regenerate 
damaged Langerhans islet β cells (Arjadi 
& Priyo, 2010). 
However, until now the 
effectiveness of the extract of P. 
macrocarpa fruit has not been tested as 
an anti-diabetes drug that can be 
aligned to other anti-diabetic drugs that 
have long been used. Therefore, this 
study aims to analyze the anti-diabetic 
effectiveness of the extract of P. 
macrocarpa pericarps compared to 
metformin as a standard drug. The 
effectiveness was evaluated based on 
its ability to re-reduce fasting blood 
sugar levels and repair pancreatic 
damage that be seen from the 
alteration of area of Langerhans islets 
after treatment in rat of diabetes 
models induced by streptozotocin (STZ).    
 
Materials and Methods 
General 
This research was conducted 
experimentally by pre and post-test with 
control group design. All of the research 
procedures have been approved by the 
Medical and Health Research Committee 
(MHREC) Faculty of Medicine, Gadjah 
Mada University. 
Material and Instrument 
This study used materials such as 
solvent of 96% ethanol, 1% 
carboxymethyl cellulose (CMC), 
metformin HCl 500 mg (Forbetes 500®), 
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streptozotocin (STZ), reagent of GOD-
PAP, ether, solution of Mayer's 
hematoxylin-eosine,  xylol and 10% 
phosphate buffer saline (PBS). While, 
instruments used include  centrifuges 
(Kubota®), water tube, 
spectrophotometer (Optima® Sp 300), 
micropipette (10 μL and 1000 μL), 
portable digital scales (Nagata®Type Lcs 
12), multihead microscopes (Nikon® 
Eclipse Ci-L) with software CellSense 
Standard®, microscopes (Motic®  B2 
Series), Optilab®, and minor surgical 
tools.  
Research Courses 
1.  Plant extraction 
P. macrocarpa fruit were 
obtained from Merapi Herbal Farma, 
Yogyakarta, Indonesia and 
authenticated at Laboratory of 
Taxonomy Faculty of Biology, 
Jenderal Soedirman University. P. 
macrocarpa pericarps was extracted 
with 96% ethanol using maceration 
techniques. The flesh of P. 
macrocarpa fruit is washed, thinly 
sliced and dried in the sun but 
covered with a black cloth to keep the 
active ingredients in control. P. 
macrocarpa pericarps that has dried 
mashed into powder. Fifty grams  of 
powder was extracted in 500 mL 96% 
ethanol by maceration (72 h)  Then, 
using a rotary vacuum evaporator to 
vaporize the remaining ethanol 96% 
solvent and then the extract is dried 
in a water-bath at a temperature of 
60-70 oC until it thickens into a paste 
(Singh, 2008). 
 
2.  Animal and experimental protocol 
Rats were obtained from the 
Laboratory of Pharmacology, Faculty 
of Medicine, Padjadjaran University, 
Bandung. The rats were housed in 
wire cages at 25-27 °C and were 
adaptated for a week at 
Pharmacology Laboratory. Thirty of 
healthy rats weighing between about 
150-200 g and 2-3-month age were 
divided in to 6 groups. All rats were 
induced with 40 mg/200 g BW of 
streptozotocin (STZ) to experience 
hyperglycemia, except group I. Group 
I as a healthy control were given 
routin care. Group II as a negative 
control were given aquadest. Group 
III, IV, and V were given the ethanol 
extract of P. macrocarpa pericarps 
with doses of 200, 250, and 300 
mg/200 g BW/day, respectively. 
Group VI was given metformin at a 
dose of 150 mg/200 g BW/day. On 
the 22nd day of treatment, blood 
specimens were taken for 
examination of fasting blood sugar 
levels and pancreatic organs for 
histopathological examination of the 
islets of Langerhans. 
3.  Blood sugar examination 
The blood sugar levels check is 
carried out using the GOD-PAP 
method with the following procedure. 
The reagent blank is measured. A 
standard solution is prepared by 
mixing 2 mL of reagent and 0.2 mL 
standard in a test tube, after the color 
turns purplish red, the standard 
solution is incubated at a 
temperature of 20-25 °C for 10 
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minutes and then, measuring the 
absorbance using a 
spectrophotometer at a wavelength 
of 546 nm (492-550 nm). A sample 
solution is further prepared by mixing 
2 mLof reagent and 0.2 mL of sample 
(serum) into a test tube and 
incubating for 10 minutes at a 
temperature of 20-25 °C. The 
absorbance is measured by using a 
spectrophotometer at a wavelength 
of 546 nm (492-550 nm). Blood sugar 
levels are determined according to 
the formula (Subiyono et al., 2016): 
 
Blood glucose level (mg/dL) = (sample absorbance/standard absorbance) x standard concentration 
 
4.  Histopathological techniques 
The pancreas organ is fixed with 
10% buffered formalin for 48 hours, 
be continued dehydration of the 
specimens in multilevel concentration 
of ethanol, cleared in xylene and the 
process of embedding into paraffin. 
After freeze, the paraffin blocks were 
cut using a microtome with a 
thickness of 5 μm and put into a 
water bath with a temperature of 42-
45 oC and dried. Then, stained with 
hematoxyline and eosin (H and E). 
The histological slides are examined 
under the light microscope which 
connected to the CellSense Standard® 
software for measuring the large of 
langerhans islets area at 200x 
magnification. The large of 
Langerhans islets area was obtained 
from the average large of five 
Langerhans islets areas of each slide. 
The repairing of the Langerhans islets 
was determined based on the 
average area of the Langerhans island 
in each study group (Guido et al., 
2011). 
5.  Statistical analysis 
The differences of blood sugar 
between pre-test and post-test were 
tested with paired sample t-test while 
the differences of blood sugar and 
the large of Langerhans islets area 
among groups of the study were 
tested with one-way anova test 
followed by post hoc test (LSD).   
 
Results and Discussion 
The blood sugar level was 
measured use GOD-PAP method by 
spectrophotometer at a wavelength of 
546 nm. The data in Table 1. show the 
information of the average of blood 
sugar levels among groups of the study 
since initial condition (before induction), 
after induction (pre-test) and after 
treatment (post-test). All groups have an 
average of normal initial blood sugar 
levels (107.40-116.00 mg/dL) and 
increased more than normal after 
induction by given streptozotocine 
(206.73-357.8 mg/dL). The normal 
fasting blood sugar levels of rat is 
108.55±7.58–122.3±16.28 mg/dL 
(Sihombing, 2011). So, diabetic rat 
models can be made establishly in this 
study. 
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Table 1. The average of blood sugar levels among groups of the study 
Groups of Study 
Mean of Blood Sugar Levels (g/dL) 
Initial  Pre-Test Post-Testb 
Ia 111.80±7.95 83.40±18.43 99.00±16.26 
IIa 116.00±2.83 302.80±110.88 252.40±122.75 
IIIa 112.20±2.49 336.20±21.12 282.80±103.94 
IVa 107.40±16.86 206.73±89.45 297.00±111.27 
Va 113.40±6.23 344.20±72.11 205.20±78.41* 
VIa 114.20±5.76 357.80±41.57 384.60±70.25 
Note: a=Paired sample t-test; *=p-value<0.05, b=one way anova and post hoc LSD test, *=p-
value<0.05 vs group VI, group I=healthy control, group II/negative control=diabetic 
models+aquadest, group III=diabetic models+ethanol extract of P. macrocarpa pericarps 
200 mg/200 g BW/day, group IV=diabetic models+ethanol extract of P. macrocarpa 
pericarps 250 mg/200 g BW/day, group V=diabetic models+ethanol extract of P. 
macrocarpa pericarps 300 mg/200 g BW/day, group VI=diabetic models+metformin 150 
mg/200 g BW/day. 
 
 
The effect of the extract of P. 
macrocarpa pericarps on blood sugar 
levels showed that the extract can 
decrease blood sugar levels between 
pre-test (before treatment) and post-
test (after treatment), as showed in 
Figure 1. The highest decreasing of blood 
sugar levels occurs in group V which 
treated with the P. macrocarpa fruit 
extract dose 300 mg/200 g BW/day. 
Statistical analysis by using paired 
sample t-test showed that there is 
significantly differences of blood sugar 
levels between pre-test and post test, 
specially in group V (p-value=0.048; CI 
95%), but were not significantly 
differences in another groups (p-
value>0.05; CI 95%), include in group VI 
which treated with metformin. 
Among groups of the study, the 
group V has a lowest of blood sugar 
levels, even when was compared to 
group VI statistically there was 
significant difference of blood sugar 
levels between a both groups (p-
value=0,005; CI 95%). This result show 
that P. macrocarpa fruit extract dose 300 
mg/200 g BW/day more effective than 
metformin dose 150 mg/200 g BW/day 
decrease to blood sugar levels on 
diabetic rat models. 
It was possible that this result 
occurs due to the content of the active 
compounds of P. macrocarpa fruit 
extract, such as tannin, terpenoids, 
hydroxy benzophenone glucoside, 
alkaloids, flavonoids, saponins, and 
polyphenols which are suspected to 
have hypoglycemic (Hendra et al., 2011). 
Alkaloids, saponins, and flavonoids are 
compounds that have antioxidant and 
antihyperglycemic effects (Ali et al., 
2012; Kumar et al., 2011). In addition, 
the extract of P. macrocarpa pericarps 
has α-glucosidase inhibitors compound 
that work to inhibit the enzymes 
hydrolase, pancreatic α-amylase, and 
other intestinal enzymes such as iso-
maltase, maltase, and sucrose. These 
enzymes will hydrolyze carbohydrates 
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which are broken down into glucose and 
other monosaccharides, thereby 
reducing glucose absorption from the 
intestine and eventually decreasing 





Figure 1. Comparison of blood sugar levels between pre-test and post-test; group 
I=healthy control, group II/negative control=diabetic models+aquadest, 
group III=diabetic models+ethanol extract of P. macrocarpa pericarps 200 
mg/200 g BW/day, group IV=diabetic models+ethanol extract of P. 
macrocarpa pericarps 250 mg/200 g BW/day, group V=diabetic 
models+ethanol extract of P. macrocarpa pericarps 300 mg/200 g BW/day, 
group VI=diabetic models+metformin 150 mg/200 g BW/day. 
 
Other mechanisms of the effects 
of P. macrocarpa fruit extract so that it 
can significantly reduce blood sugar 
levels occur through effects that 
increase blood glucose transport into 
cells, stimulate glycogen synthesis and 
inhibit glucose synthesis by inhibiting the 
enzyme 6-phosphatase, fructose 1,6-
bisphosphatase, and increase glucose 
oxidation through glucose 6-phosphate 
dehydrogenase. Inhibition of these 
enzymes will reduce glucose formation 
from   non-carbohydrates substrates 
(Arjadi & Priyo, 2010; Ali et al., 2012). 
In group VI which were given 
metformin should be able to reduce 
blood sugar levels significantly but in this 
study blood sugar levels increased 
although not significantly (p-value= 
0.442; CI 95%). Based on literature 
study, it is known that this condition can 
occur in connection with the nature of 
the effects of the drug metformin as a 
time-dependent drug. The hypoglycemic 
effect of metformin occurs after 28 days 
of use (Erejuwa et al., 2011). In this 
study, metformin was given for 21 days 
so that it had not reached the time of 
effective use to cause hypoglycemic 
effects. 
In this study it can also be seen 
that the effect of the extract of P. 
macrocarpa pericarps on blood sugar 
levels of diabetic rat models shows as a 
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dose-dependent drug, i.e the higher the 
dose the stronger the effect. The dose of 
300 mg/200 g BW/day as the highest 
dose used in this study showed the 
highest effectiveness compared to other 
groups, as shown in Table 1. However, 
these findings need to be confirmed 
through further research using a higher 
dose range and evaluation of possible 
toxic effects. 
The repairing of the Langerhans 
islets was determined based on the 
average area of the Langerhans island in 
each study group. The area of the 
pancreatic Langerhans islets was 
measured using a microscope connected 
to CellSense Standard® software on 
histology slides with hematoxylin eosin 
(HE) staining at 200x magnification. The 
area of the Langerhans islets measured 
as shown in Figure 2. 
In general, the largest average 
area of the Langerhans islets was found 
at group I which is a healthy control 
group (7473.20±420.6 µm2) as shown in 
Figure 3. In the research group the fruit 
extracts P. macrocarpa, the largest 
average area of Langerhans is in group V 
(3938.60±572.42 µm2) and the smallest 
was found in group III (1944.75±213.15 
µm2) while the group VI given metformin 
has an average area of Langerhans islets 
is 3442.75±518 µm2 or smaller than 
group V. 
Statistical analysis showed that 
there were significant differences of the 
average area of the Langerhans islets 
between the study groups (p=0.000; CI 
95%). Significantly differences of the 
average area of the Langerhans island 
were mainly found between group I with 
all other research groups (p value=0.000; 
CI 95%), group II with groups V and VI (p 
values=0.000 and 0.009; CI 95%), group 
III with group V and VI (p values=0.000 
and 0.001; CI 95%) and also group IV and 
V (p values=0.003; CI 95%). The results of 
this analysis showed that group V which 
treated with P. macrocarpa fruit extract 
dose of 300 mg/200 g BW/day had the 
highest effectiveness in repairing cells 
damage of Langerhans islets compared 
with other groups and even with group 




Figure 2. Boundary area measurement area of the Langerhans islets. 
 
PHARMACY: Jurnal Farmasi Indonesia                                                          p-ISSN 1693-3591 
(Pharmaceutical Journal of Indonesia)                                                          e-ISSN 2579-910X 





Figure 3. The average area of Langerhans islets in each study group, bone way anova and 
post hoc LSD test, *p-value<0.05 vs group II and III. Group I=healthy control, 
group II/negative control=diabetic models+aquadest, group III=diabetic 
models+ethanol extract of P. macrocarpa pericarps 200 mg/200 g BW/day, 
group IV=diabetic models+ethanol extract of P. macrocarpa pericarps 250 
mg/200 g BW/day, group V=diabetic models+ethanol extract of P. macrocarpa 
pericarps 300 mg/200 g BW/day, group VI=diabetic models+metformin 150 
mg/200 g BW/day. 
 
 
The extract of P. macrocarpa 
pericarps has anti-hyperglycemia and 
antioxidant effects that can reduce 
blood sugar levels and repairing the 
damage of Langerhans islets. As it is 
known that the condition of 
hyperglycemia can trigger oxidative 
stress which will result in β cell apoptosis 
and ends with damage to the 
Langerhans islets. The effects of 
hypoglycemia and antioxidant of extracts 
will prevent this condition. The 
antioxidant effect of flavonoid 
compounds has been known able to 
neutralize free radicals that accumulate 
in cells due to diabetes mellitus, thereby 
reducing oxidative stress and stopping 
the destruction of β cells in the 
Langerhans islets. In addition, flavonoids 
can also stimulate the regeneration 
process of Langerhans islets (Choi et al., 
2009). Whereas the content of other 
compounds such as benzophenone 
glycoside derivatives is thought to have 
the activity of suppressing cell apoptosis 
mediated by caspase-3 activation, 
increasing β cell proliferation so that it 
can repair damaged the Langerhans 
islets which in this study are shown by its 
ability to prevent futher damage of the 
langerhans islets compared to the 
negative control group (group II) (Oshimi 
et al., 2008). 
The results of this study also 
prove that metformin can also repairing 
damage of the Langerhans islets of 
diabetic rat models, although in this 
study it was less effective than P. 
macrocarpa fruit extracts. These results 
are in accordance with the research of 
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Murad et al. (2015) which proves that 
metformin and pioglitazone given with 
or without combination can provide a 
better regeneration effect on the 
Langerhans islets, reduce oxidative 
stress, inhibit cell apoptosis and increase 
cell mass in the Langerhans islets on 
diabetic rat models. 
The results of this study also 
prove that metformin can also repairing 
damage of the Langerhans islets of 
diabetic rat models, although in this 
study it was less effective than P. 
macrocarpa fruit extracts. These results 
are in accordance with the research of 
Murad et al. (2015) which proves that 
metformin and pioglitazone given with 
or without combination can provide a 
better regeneration effect on the 
Langerhans islets, reduce oxidative 
stress, inhibit cell apoptosis and increase 
cell mass in the Langerhans islets on 
diabetic rat models. 
However, the results of this 
study are still incomplete. Although the 
extract of P. macrocarpa pericarps has 
shown hypoglycemic effects but these 
effects have not been able to achieve 
the condition of blood sugar levels and 
area of the langerhans islets as same as 
healthy control group. The tendency of 
pharmacological effects of the extract of 
P. macrocarpa pericarps is dose-
dependent drug so there is a possibility 
that effectiveness will increase along 
with increasing dose. This requires 
further research with a higher dose 
range and conducting toxicological tests 
to identify possible toxic effects. 
 
Conclusion 
The results of this study can be 
concluded that the extract of P. 
macrocarpa pericarps had a 
hypoglycemic effect and repaired 
damage to the Langerhans islets of STZ-
induced rat pancreas and an increase in 
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